Deerfield Management Company »

Customers Ban shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Customers Ban (CUBI) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Customers Ban

Tip: Access up to 7 years of quarterly data

All positions including Customers Ban held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Customers Ban by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $248k 4.3k 57.62

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Customers Ban

Dimensional Fund Advisors
Vanguard Group
Wellington Management Company
Jpmorgan Chase & Co
Jacobs Levy Equity Management
Toroso Investments
Charles Schwab Investment Management
LSV Asset Management
Wintrust Financial Corporation
Access Investment Management
Royce & Associates
Allspring Global Investments Holdings
Bank of New York Mellon
Goldman Sachs Group
Tieton Capital Management

View all funds holding Customers Ban